Search Results

Containing any of the words

Only of the type

An Adaptive, Randomized, Placebo-controlled, Double-blind, Multi-center Study of Oral FT-4202, a Pyruvate Kinase Activator in Patients with Sickle Cell Disease Drug Clinical Trial

A Long-Term Extension Study of Nusinersen (BIIB058) Administered at Higher Doses in Participants With Spinal Muscular Atrophy Who Previously Participated in an Investigational Study With Nusinersen Drug Clinical Trial

(WU2249) NCMDR Weakly Update Medical Report

Approach of Dealing with Patents When Register Generic Drugs in SFDA Regulations

Drug Master File : Guidance for Submission Forms

Hydroxychloroquine Risk Minimization Activity

Annual Report 2021 Annual Report

SFDA Participates in International Gathering to Harmonize Technical Needs for Human Medicines News

(WU2250) NCMDR Weakly Update Medical Report

Clearance conditions and requirements of public health pesticides Regulations